Diagnóstico etiológico de la sordera infantil: Recomendaciones CODEPEH 2015

  • Faustino Núñez Batalla Hospital Universitario Central de Asturias-Oviedo. Sociedad Española de Otorrinolaringología
  • Carmen Jáudenes Casaubón Confederación Española de Familias de Personas Sordas (FIAPAS)
  • José Miguel Sequí Canet Hospital de Gandía-Valencia. Asociación Española de Pediatría
  • Ana Vivanco Allende Hospital Universitario Central de Asturias-Oviedo. Asociación Española de Pediatría
  • José Zubicaray Ugarteche Complejo Hospitalario de Navarra-Pamplona. Sociedad Española de Otorrinolaringología
  • Rubén Cabanillas Farpón Instituto de Medicina Oncológica y Molecular de Asturias (IMOMA)
Palabras clave: Sordera, diagnóstico, etiología, genética, hipoacusia, Atención Temprana.

Resumen


Núñez, F. et al. (2016): “Diagnóstico etiológico de la sordera infantil: Recomendaciones CODEPEH 2015”, Revista Española de Discapacidad, 4 (1): 193-218.

Biografía del autor/a

Faustino Núñez Batalla, Hospital Universitario Central de Asturias-Oviedo. Sociedad Española de Otorrinolaringología

Presidente de la Comisión para la Detección Precoz de la Sordera (CODEPEH) en representación de la Sociedad Española de Otorrinolaringología. Médico del Servicio de Otorrinolaringología del Hospital Universitario Central de Asturias y profesor de la Universidad de Oviedo.

Carmen Jáudenes Casaubón, Confederación Española de Familias de Personas Sordas (FIAPAS)

Directora de la Confederación Española de Familias de Personas Sordas (FIAPAS) y vocal de la Comisión para la Detección Precoz de la Sordera (CODEPEH). Es pedagoga y logopeda.

José Miguel Sequí Canet, Hospital de Gandía-Valencia. Asociación Española de Pediatría

Jefe de Pediatría del Hospital de Gandía-Valencia y vocal de la Comisión para la Detección Precoz de la Sordera (CODEPEH).

Ana Vivanco Allende, Hospital Universitario Central de Asturias-Oviedo. Asociación Española de Pediatría

Trabaja en el Servicio de Pediatría del Hospital Universitario Central de Asturias-Oviedo y es vocal de la Comisión para la Detección Precoz de la Sordera (CODEPEH).

José Zubicaray Ugarteche, Complejo Hospitalario de Navarra-Pamplona. Sociedad Española de Otorrinolaringología
Médico especialista en Otorrinolaringología Infantil en el Complejo Hospitalario de Navarra-Pamplona y es vocal de la Comisión para la Detección Precoz de la Sordera (CODEPEH).
Rubén Cabanillas Farpón, Instituto de Medicina Oncológica y Molecular de Asturias (IMOMA)
Director médico del Instituto de Medicina Oncológica y Molecular de Asturias (IMOMA).

Citas

Alarcón, A. y Baquero-Artigao, F. (2011): “Revisión y recomendaciones sobre la prevención, diagnóstico y tratamiento de la infección posnatal por citomegalovirus”. Anales de Pediatría, 74: 52.e1-52.e13.

Alford, R.L. et al. (2014): “ACMG Working Group on Update of Genetics Evaluation Guidelines for the Etiologic Diagnosis of Congenital Hearing Loss; Professional Practice and Guidelines Committee. American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss”. Genet Med, 16: 347-355.

American Academy of Pediatrics et al. (2006): “Guidelines for Monitoring and Management of Pediatric Patients During and After Sedation for Diagnostic and Therapeutic Procedures”. Pediatrics, 118 (6): 2587-2602. Reaffirmed March 2011.

Atik, T. et al. (2015): “M. Whole-exome sequencing and its impact in hereditary hearing loss”. Genet Res (Camb), 97: e4.

Badia, J. et al. (2014): “Infecciones congénitas”. Pediatr Integral, 18: 356-366.

Barkai, G. et al. (2014): “Universal neonatal cytomegalovirus screening using saliva - report of clinical experience”. J Clin Virol, 60: 361-366.

Behar, D.M. et al. (2014): “The many faces of sensorineural hearing loss: one founder and two novel mutations affecting one family of mixed Jewish ancestry”. Genet Test Mol Biomarkers, 18: 123-126.

Bockmühl, U. et al. (2001): “Visualization of inner ear displasias in patients with sensorineural hearing loss”. Acta Radiológica, 42: 574-581.

Boppana, S.B. et al. (2010): “Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection”. JAMA, 303: 1375-1382.

Botet, F. et al. (2015): “Cribado universal de infección por citomegalovirus en prematuros de menos de 1.500 g”. Anales de Pediatría, 83: 69.

Botet, F. et al. (2014): “Cribado universal de infección por citomegalovirus en prematuros de menos de 1.500 g”. Anales de Pediatría, 81: 256.e1-4.

Brenner, D.J. et al. (2001): “Estimated Risk of radiation Induced Fatal Cancer from Pediatric CT AJR”. American Journal of Roentgenology, 176 (2): 289-296.

Brownstein, Z. et al. (2011): “Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families”. Genome Biol., 12: R89.

Cabanillas, R. y Cadiñanos, J. (2012): “Hipoacusias hereditarias: asesoramiento genético”. Acta Otorrinolaringol Esp., 63: 218-229.

Cabanillas, R. et al. (2011): “Nestor-Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations”. Am J Med Genet A.; 155A: 2617-2625.

Cannon, M.J. et al. (2014): “Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?”. Rev Med Virol, 24: 291-307.

Cardoso, E.S. et al. (2015): “The use of saliva as a practical and feasible alternative to urine in large-scale screening for congenital cytomegalovirus infection increases inclusion and detection rates”. Rev. Soc. Bras. Med. Trop, 48: 206-207.

Casselman, J.W. et al. (1996): “Inner ear malformations in patients with sensorineural hearing loss: detection with gradient-echo (3DFT-CISS) MRI”. Neuroradiology; 38 (3): 278-286.

del Castillo, F.J. et al. (2005): “A novel deletion involving the connexin-30 gene, del (GJB6-d13s1854), found in trans with mutations in the GJB2 gene (connexin-26) in subjects with DFNB1 non-syndromic hearing impairment”. J Med Genet, 42: 588-594.

Chiang, C.E. (2004): “Congenital and acquired long QT syndrome. Current concepts and management”. Cardiol Rev., 12: 222-234.

Choi, B.Y. et al. (2013): “Diagnostic application of targeted resequencing for familial nonsyndromic hearing loss”. PLoS One., 8: e68692.

Choi, B.Y. et al. (2009): “Detection of cytomegalovirus DNA in dried blood spots of Minnesota infants who do not pass newborn hearing screening”. Pediatr Infect Dis J, 28: 1095-1098.

Cohen, B.E. et al. (2014): “Viral causes of hearing loss: a review for hearing health professionals”. Trends Hear, 18: 1-17.

Crotti et al. (2008): “Congenital long QT syndrome”. Orphanet Journal of Rare Diseases, 3: 18.

Çelikel, E. et al. (2015): “Evaluation of 98 immunocompetent children with cytomegalovirus infection: importance of neurodevelopmental follow-up”. Eur J Pediatr., 174 (8): 1101-1107.

Dahle, A.J. y McCollister, F.P. (1988): “Audiological findings in children with neonatal herpes”. Ear Hear, 9: 256-258.

De Vries, J.J. et al. (2013): “Cytomegalovirus DNA detection in dried blood spots and perilymphatic fluids from pediatric and adult cochlear implant recipients with prelingual deafness”. J Clin Virol, 56: 113-117.

Declau, F. et al. (2008): “Etiologic and audiologic evaluations after universal neonatal hearing screening: analysis of 170 referred neonates”. Pediatrics, 121: 1119-1126.

Deklerck, A.N. et al. (2015): “Etiological approach in patients with unidentified hearing loss”. Int J Pediatr Otorhinolaryngol., 79: 216-222.

Demmler-Harrison, G. (2015): Congenital cytomegalovirus infection: Clinical features and diagnosis (en línea). <http://www.uptodate. com/contents/congenital-cytomegalovirus-infection-clinicalfeatures-and-diagnosis>, acceso 7 de julio de 2015.

Dyer J.J. et al. (1988): “Teratogenic hearing loss: a clinical perspective”. Am J Otol., 19: 671-678.

Escosa-García, L. et al. (2015): “Cribado de citomegalovirus en prematuros menores de 1.500 g. Comité Científico del Registro Estatal de Infección Congénita por Citomegalovirus”. An Pediatr., 83: 70-71.

Estivill, X. et al. (1998): “Connexin-26 mutations in sporadic and inherited sensorineural deafness”. Lancet., 351: 394-398.

Gallo-Terán, J. et al. (2005): “Prevalence of the 35delG mutation in the GJB2 gene, del (GJB6- D13S1830) in the GJB6 gene, Q829X in the OTOF gene and A1555G in the mitochondrial 12S rRNA gene in subjects with non-syndromic sensorineural hearing impairment of congenital/ childhood onset”. Acta Otorrinolaringol Esp., 56: 463-468.

Goderis, J. et al. (2014): “Hearing loss and congenital CMV infection: a systematic review”. Pediatrics, 134: 972-982.

Green, R.C. et al. (2013): “ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing”. Genet Med., 15: 565-574.

Gu, X. et al. (2013): “Genetic testing for sporadic hearing loss using targeted massively parallel sequencing identifies 10 novel mutations”. Clin Genet., 87: 588-593.

Gunkel, J. et al. (2014): “Urine is superior to saliva when screening for postnatal CMV infections in preterm infants”. J Clin Virol, 61: 61-64.

Jacobson, S.G. et al. (2015): “Improvement and decline in vision with gene therapy in childhood blindness”. N Engl J Med., 372: 1920-1926.

Jamuar, S.S. y Tan, E.C. (2015): “Clinical application of next-generation sequencing for Mendelian diseases”. Hum Genomics., 9: 10.

Ji, H. et al. (2014): “Combined examination of sequence and copy number variations in human deafness genes improves diagnosis for cases of genetic deafness”. BMC Ear Nose Throat Disord., 14: 9.

Joint Committee on Infant Hearing (2007): “Year 2007 position statement: principles and guidelines for early hearing detection and intervention programs”. Pediatrics, 120: 898- 921.

Kadambari, S. et al. (2015): “Evaluating the feasibility of integrating salivary testing for congenital CMV into the Newborn Hearing Screening Programme in the UK”. Eur J Pediatr., 174 (8): 1117-1121.

Kadambari, S. et al. (2013): “Clinically targeted screening for congenital CMV - potential for integration into the National Hearing Screening Programme”. Acta Pediatr; 102: 928-933.

Karltorp, E. et al. (2012): “Congenital cytomegalovirus infection - a common cause of hearing loss of unknown aetiology”. Acta Pediatr, 101: e357-62.

Kenneson, A. et al. (2002): “GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HuGE review”. Genet Med., 4: 258-274.

Kimberlin, D.W. et al. (2015): “Valganciclovir for symptomatic congenital cytomegalovirus disease”. N Engl J Med, 372: 933-943.

Kochhar, A. et al. (2007): “Clinical aspects of hereditary hearing loss”. Genet Med., 9: 393- 408.

Kohda, C. et al. (2014): “A simple smart amplification assay for the rapid detection of human cytomegalovirus in the urine of neonates”. J Virol Methods, 208: 160-165.

Koontz, D. et al. (2015): “Evaluation of DNA extraction methods for the detection of Cytomegalovirus in dried blood spots”. J Clin Virol., 66: 95-99.

Laury et al. (2009): “Etiology of unilateral neural hearing loss in children”. International Journal of Pediatric Otorhinolaringology, 73: 417-427.

Lee, C.I. et al. (2004): “Diagnostic CT Scans: Assessment of Patient, Physician, and Radiologist Awareness of Radiation Dose and Possible Risks”. Radiology, 231: 393-398.

Lemmerling, M. y Foer, B. (eds.) (2015): “Temporal Bone Imaging”. Springer-Verlag Berlin Heidelberg.

Lim, B.G. et al. (2013): “Utility of genetic testing for the detection of late-onset hearing loss in neonates”. Am J Audiol, 22: 209-215.

Lin, J.W. et al. (2011): “Comprehensive diagnostic battery for evaluating sensorineural hearing loss in children”. Otol Neurotol., 32: 259-264.

Lu, Y. et al. (2014): “Resolving the genetic heterogeneity of prelingual hearing loss within one family: Performance comparison and application of two targeted next generation sequencing approaches”. J Hum Genet., 59: 599-607.

MacLaren, R.E. et al. (2014): “Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial”. Lancet., 383: 1129-1137.

Madden, C. et al. (2007): “The influence of mutations in the SLC26A4 gene on the temporal bone in a population with enlarged vestibular aqueduct”. Arch Otolaryngol Head Neck Surg., 133: 162-168.

Mafong, D.D. et al. (2002): “Use of laboratory evaluation and radiologic imaging in the diagnostic evaluation of children with sensorineural hearing loss”. Laryngoscope, 112: 1-7.

Muller, U. y Barr-Gillespie, P.G. (2015): “New treatment options for hearing loss”. Nat Rev Drug Discov., 14: 346-365.

Núñez, F. et al. (2015): “Recomendaciones CODEPEH 2014”, Revista Española de Discapacidad, 3 (1): 163-186.

Nuñez-Ramos, R. et al. (2013): “Early diagnosis of congenital cytomegalovirus infection: lost opportunities”. Enferm Infecc Microbiol Clin, 31: 93-96.

Palmer, C.G. et al. (2009): “A prospective, longitudinal study of the impact of GJB2/GJB6 genetic testing on the beliefs and attitudes of parents of deaf and hard-of-hearing infants”. Am J Med Genet A., 149A: 1169-1182.

Park, A.H. et al. (2014): “A diagnostic paradigm including cytomegalovirus testing for idiopathic pediatric sensorineural hearing loss”. Laryngoscope, 124: 2624-2629.

Preciado, D.A. et al. (2005): “Improved diagnostic effectiveness with a sequential diagnostic paradigm in idiopathic pediatric sensorineural hearing loss”. Otol Neurotol, 26: 610-615.

Pickett, B.P. y Ahlstrom, K. (1999) “Clinical evaluation of the hearing-impaired infant”. Otolaryngol Clin North Am., 32: 1019-1035.

Rangan, S. et al. (2012): “Deafness in children: a national survey of aetiological investigations”. BMJ Open, 2: e001174.

Rehm, H.L. (2013). “Disease-targeted sequencing: a cornerstone in the clinic”. Nat Rev Genet., 14: 295-300.

Rehm, H.L. et al. (2013): “ACMG clinical laboratory standards for next-generation sequencing”. Genet Med., 15: 733-747.

Robin, N.H. et al. (2015): “The use of genetic testing in the evaluation of hearing impairment in a child”. Curr Opin Pediatr., 17: 709-712.

Ross, S. et al. (2015): “Urine Collection Method for the Diagnosis of Congenital Cytomegalovirus Infection”. Pediatr Infect Dis J., 34: 903-905.

Sando, I. et al. (1998): “Frequency and localization of congenital anomalies of the middle and inner ears: a human temporal bone histopathologicalstudy”. Int J Pediatric Otorhinolaryngol., 16 (1): 1-22.

Sanger, F. y Coulson, A.R. (1975): “A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase”. J Mol Biol., 94: 441-448.

Schimmenti, L.A. et al. (2011): “Evaluation of newborn screening bloodspot-based genetic testing as second tier screen for bedside newborn hearing screening”. Genet Med, 13: 1006-1010.

Schleiss, M.R. (2013): “Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?”. Future Virol, 8: 1161-1182.

Schrauwen, I. et al. (2013): “A sensitive and specific diagnostic test for hearing loss using a microdroplet PCR-based approach and next generation sequencing”. Am J Med Genet A., 161A: 145-152.

Shearer, A.E. y Smith, R.J. (2015): “Massively Parallel Sequencing for Genetic Diagnosis of Hearing Loss: The New Standard of Care”. Otolaryngol Head Neck Surg., 153: 175-182.

Shearer, A.E. et al. (2014): “Copy number variants are a common cause of non-syndromic hearing loss”. Genome Med., 6: 37.

Shearer, A.E. et al. (2013): “Advancing genetic testing for deafness with genomic technology”. J Med Genet., 50: 627-634.

Shearer, A.E. et al. (2010): “Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing”. Proc Natl Acad Sci U S A., 107 (49): 21.104-21.109.

Singh, D. et al. (2015): “MR Evaluation of vestibulocochear Neuropathy”. J Neuroimaging, 1038-1430.

Smiechura, M. et al. (2014): “Congenital and acquired cytomegalovirus infection and hearing evaluation in children”. Otolaryngol Pol, 68: 303-307.

Takemori, S. et al. (1976): “Thalidomideanomalies of theear”. Arch Otolaryngol, 102: 425-427.

Teek, R. et al. (2013): “Hearing impairment in Estonia: an algorithm to investigate genetic causes in pediatric patients”. Adv Med Sci, 58: 419-428.

Tekin, D. et al. (2014): “Comprehensive genetic testing can save lives in hereditary hearing loss”. Clin Genet., 87: 190-191.

Thomas, K.E. et al. (2006): “Assessment of radiation dose awareness among pediatricians”. Pediatr Radiol., 36: 823-832.

Toumpas, C.J. et al. (2014): “Congenital cytomegalovirus infection is a significant cause of moderate to profound sensorineural hearing loss in Queensland children”. Journal of Paediatrics and Child Health, 51: 541–544.

Trinidad, G. et al. (2010): “Recomendaciones de la Comisión para la Detección Precoz de la Hipoacusia (CODEPEH) para 2010”. Acta Otorrinolaringol. Esp, 61: 69-77.

Valvassori, G.E. et al. (1969): “Inner ear anomalies: clinical and histopathological considerations”. Ann Otol Rhinol Laryngol., (5): 929-938.

Vona, B. et al. (2015): “Non-syndromic hearing loss gene identification: A brief history and glimpse into the future”. Mol Cell Probes, 29 (5): 260-270.

Vona, B. et al. (2014): “Targeted next-generation sequencing of deafness genes in hearingimpaired individuals uncovers informative mutations”. Genet Med., 16: 945- 953.

Wang, D. y Fu, T.M. (2014): “Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease”. Curr Opin Virol, 6: 13-23.

Wei, X. et al. (2012): “Next-generation sequencing identifies a novel compound heterozygous mutation in MYO7A in a Chinese patient with Usher Syndrome 1B”. Clin Chim Acta., 413: 1866-1871.

Williams, E.J. et al. (2015): “First estimates of the potential cost and cost saving of protecting childhood hearing from damage caused by congenital CMV infection”. Arch Dis Child Fetal Neonatal, 100 (6): F501-F506.

Williams, E.J. et al. (2014): “Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss”. Arch Dis Child Fetal Neonatal, 99: F230-F236.

Young, T.L. et al. (2001): “Nom - syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram Syndrome gene WFS1”. Hum Mol Genet, 10: 2509-2514.

Yu, Q. et al. (2014): “Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice”. Gene Ther., 21: 71-80.

Publicado
2016-06-29